Skip to content
The Nexus
DossierENTITY

Breyanzi

Coverage of Breyanzi in the Nexus archive.

Earliest in view: Aug 2 · 21:27 UTCMost recent: Aug 2 · 21:27 UTC
Co-mentioned in this coverage
AstraZenecaorganization1Bristol Myers Squibborganization1Eliquistopic1Opdivotopic1Opdualagtopic1Camzyostopic1
Recent coverage
  • BUSINESSAug 2 · 21:27 UTCFORTUNE
    AstraZeneca said to have explored Bristol Myers merger

    AstraZeneca Plc explored an acquisition of Bristol Myers Squibb Co., which could create one of the world's largest drugmakers. Bristol Myers Squibb, with a $133 billion market capitalization, faces patent losses for key drugs like Eliquis and Opdivo, while AstraZeneca has a market value of about £196 billion. Bristol recently reported record quarterly sales of $13 billion driven by newer treatments.

Breyanzi · Dossier · The Nexus